US Stock MarketDetailed Quotes
AADI Aadi Biosciences
- 1.940
- +0.020+1.04%
Close May 1 16:00 ET
- 1.930
- -0.010-0.52%
Post 19:28 ET
47.64MMarket Cap-795P/E (TTM)
1.980High1.885Low186.42KVolume1.930Open1.920Pre Close360.26KTurnover1.17%Turnover RatioLossP/E (Static)24.55MShares8.60052wk High0.45P/B30.85MFloat Cap1.55052wk Low--Dividend TTM15.90MShs Float65.250Historical High--Div YieldTTM4.95%Amplitude1.550Historical Low1.932Avg Price1Lot Size
Aadi Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -20.19%-59.66M | 14.73%-9.64M | -45.83%-11.95M | -56.32%-16.76M | -9.76%-21.31M | -121.38%-49.64M | 9.00%-11.31M | 52.83%-8.2M | -236.58%-10.72M | -283.80%-19.42M |
| Net income from continuing operations | -8.68%-65.77M | -16.93%-16.27M | -12.63%-16.3M | 1.63%-17.97M | -9.86%-15.22M | 45.03%-60.51M | 12.99%-13.91M | 83.38%-14.47M | -1,089.39%-18.27M | -153.05%-13.86M |
| Depreciation and amortization | 6.29%169K | -4.35%44K | 266.67%44K | 59.26%43K | -48.65%38K | 51.43%159K | -36.11%46K | -58.62%12K | 1,250.00%27K | 3,600.00%74K |
| Other non cash items | 35.86%519K | 2.68%115K | 5,850.00%115K | -22.30%115K | 40.32%174K | -54.31%382K | -5.88%112K | -101.13%-2K | -45.59%148K | -53.73%124K |
| Change In working capital | -87.03%-3.4M | 499.22%3.84M | -52.72%1.73M | -180.35%-1.14M | -4.01%-7.84M | -114.86%-1.82M | -67.76%641K | 174.47%3.66M | 133.88%1.42M | -151.74%-7.54M |
| -Change in receivables | -94.74%-3.63M | -42.61%229K | -930.81%-2.04M | 192.87%1.89M | -36.74%-3.7M | -113.16%-1.86M | --399K | ---198K | 437.50%645K | -119.30%-2.71M |
| -Change in inventory | -75.44%-3.27M | -97.43%-2.23M | 4,700.00%322K | 210.48%580K | -861.39%-1.94M | ---1.86M | ---1.13M | ---7K | ---525K | ---202K |
| -Change in prepaid assets | 346.27%3.6M | 794.78%1.03M | 264.04%1.73M | 2,603.64%1.49M | -10.88%-642K | 32.46%-1.46M | 107.01%115K | -153.98%-1.05M | 150.00%55K | -57,800.00%-579K |
| -Change in payables and accrued expense | -104.10%-132K | 269.53%4.82M | -65.73%1.72M | -603.54%-5.13M | 62.61%-1.54M | -61.16%3.22M | -62.01%1.3M | 38.25%5.03M | 61.33%1.02M | -797.47%-4.13M |
| -Change in other current assets | 18.54%518K | 66.67%120K | 51.85%123K | 0.00%159K | -7.20%116K | -9.15%437K | 41.18%72K | -81.16%81K | --159K | --125K |
| -Change in other current liabilities | -72.51%-502K | -4.96%-127K | 33.86%-125K | -300.00%-126K | -181.82%-124K | 96.58%-291K | -182.31%-121K | 97.79%-189K | 275.00%63K | 15.38%-44K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -20.19%-59.66M | 14.73%-9.64M | -45.83%-11.95M | -56.32%-16.76M | -9.76%-21.31M | -121.38%-49.64M | 9.00%-11.31M | 52.83%-8.2M | -236.58%-10.72M | -283.80%-19.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 162.61%83.21M | 104.32%3.65M | 126.26%12.67M | 21,079.67%50.56M | 71,095.65%16.33M | -628.31%-132.89M | -183,332.61%-84.38M | -290.26%-48.24M | -53.50%-241K | -23K |
| Net PPE purchase and sale | -794.59%-3.97M | -946.15%-816K | -976.47%-1.1M | -185.89%-689K | -5,852.17%-1.37M | -865.22%-444K | -69.57%-78K | ---102K | ---241K | ---23K |
| Net investment purchase and sale | 165.82%87.18M | 105.30%4.47M | 128.59%13.77M | --51.25M | --17.7M | ---132.44M | ---84.3M | ---48.14M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 162.61%83.21M | 104.32%3.65M | 126.26%12.67M | 21,079.67%50.56M | 71,095.65%16.33M | -628.31%-132.89M | -183,332.61%-84.38M | -290.26%-48.24M | -53.50%-241K | ---23K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.55%326K | 174.77%80K | -100.10%-75K | 459.77%313K | -97.32%8K | -48.79%72.62M | -221.59%-107K | -48.83%72.52M | -8,600.00%-87K | 298K |
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | -53.23%72.5M | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -37.61%486K | -65.35%114K | -87.50%2K | 166.18%362K | -97.32%8K | -6.48%779K | 273.86%329K | -97.85%16K | --136K | --298K |
| Net other financing activities | 75.72%-160K | 92.20%-34K | ---77K | ---- | ---- | 93.15%-659K | ---436K | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.55%326K | 174.77%80K | -100.10%-75K | 459.77%313K | -97.32%8K | -48.79%72.62M | -221.59%-107K | -48.83%72.52M | -8,600.00%-87K | --298K |
| Net cash flow | ||||||||||
| Beginning cash position | -73.77%39.08M | -48.94%68.87M | -42.57%68.23M | -73.73%34.11M | -73.77%39.08M | 3,244.31%148.99M | -16.42%134.88M | 917.57%118.8M | 764.62%129.85M | 3,244.31%148.99M |
| Current changes in cash | 121.72%23.87M | 93.83%-5.92M | -96.01%641K | 408.80%34.12M | 74.02%-4.97M | -176.04%-109.91M | -673.42%-95.8M | -89.26%16.08M | -230.48%-11.05M | -281.20%-19.14M |
| End cash Position | 61.07%62.95M | 61.07%62.95M | -48.94%68.87M | -42.57%68.23M | -73.73%34.11M | -73.77%39.08M | -73.77%39.08M | -16.42%134.88M | 917.57%118.8M | 764.62%129.85M |
| Free cash flow | -27.06%-63.64M | 8.15%-10.46M | -57.27%-13.05M | -59.17%-17.45M | -16.67%-22.68M | -122.90%-50.08M | 8.71%-11.39M | 52.24%-8.3M | -244.14%-10.96M | -284.02%-19.44M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg